Contribution of humoral immunity to the therapeutic response in falciparum malaria.

The contribution of humoral immunity to the therapeutic response in acute falciparum malaria was assessed in a case-control study. Forty adult Thai patients with acute falciparum malaria who had subsequent recrudescent infections and 40 patients matched for age, therapeutic regimen, and disease seve...

Full description

Bibliographic Details
Main Authors: Mayxay, M, Chotivanich, K, Pukrittayakamee, S, Newton, P, Looareesuwan, S, White, N
Format: Journal article
Language:English
Published: 2001
_version_ 1797053858316288000
author Mayxay, M
Chotivanich, K
Pukrittayakamee, S
Newton, P
Looareesuwan, S
White, N
author_facet Mayxay, M
Chotivanich, K
Pukrittayakamee, S
Newton, P
Looareesuwan, S
White, N
author_sort Mayxay, M
collection OXFORD
description The contribution of humoral immunity to the therapeutic response in acute falciparum malaria was assessed in a case-control study. Forty adult Thai patients with acute falciparum malaria who had subsequent recrudescent infections and 40 patients matched for age, therapeutic regimen, and disease severity who were cured by Day 28 were studied. All cured patients had positive immunoglobulin (Ig) G to ring-infected erythrocyte surface antigen (RESA) in their admission plasma, compared with only 60% of patients who failed to respond to treatment (P < 0.001). The proportion of IgM-positive cases at admission was also higher in the successfully treated group than in the group with failure (70% versus 30%) (P < 0.001). The geometric mean (95% confidence interval) reciprocal IgG titer at admission was significantly higher in cured patients (187.0 [83.5-418.3]) compared with those who experienced treatment failure (11.6 [5.1-26.5]) (P < 0.001). The patients with uncomplicated malaria who were both IgG and IgM positive at admission had significantly shorter fever clearance times and lower admission parasitemia levels compared with those who were negative (P = 0.01 and P = 0.02, respectively). The median (range) in vitro parasite multiplication rate was significantly lower in cultures containing positive anti-RESA antibody plasma compared with those containing normal plasma (0.7 [0.1-3.5] versus 2.6 [0.1-12.1]; P < 0.001). These results suggest that antimalarial antibodies may play an important supportive role in the therapeutic response to antimalarial drugs during acute falciparum malaria.
first_indexed 2024-03-06T18:49:26Z
format Journal article
id oxford-uuid:0fb005a3-28b6-4a09-b717-1e63c17c47ca
institution University of Oxford
language English
last_indexed 2024-03-06T18:49:26Z
publishDate 2001
record_format dspace
spelling oxford-uuid:0fb005a3-28b6-4a09-b717-1e63c17c47ca2022-03-26T09:52:31ZContribution of humoral immunity to the therapeutic response in falciparum malaria.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0fb005a3-28b6-4a09-b717-1e63c17c47caEnglishSymplectic Elements at Oxford2001Mayxay, MChotivanich, KPukrittayakamee, SNewton, PLooareesuwan, SWhite, NThe contribution of humoral immunity to the therapeutic response in acute falciparum malaria was assessed in a case-control study. Forty adult Thai patients with acute falciparum malaria who had subsequent recrudescent infections and 40 patients matched for age, therapeutic regimen, and disease severity who were cured by Day 28 were studied. All cured patients had positive immunoglobulin (Ig) G to ring-infected erythrocyte surface antigen (RESA) in their admission plasma, compared with only 60% of patients who failed to respond to treatment (P < 0.001). The proportion of IgM-positive cases at admission was also higher in the successfully treated group than in the group with failure (70% versus 30%) (P < 0.001). The geometric mean (95% confidence interval) reciprocal IgG titer at admission was significantly higher in cured patients (187.0 [83.5-418.3]) compared with those who experienced treatment failure (11.6 [5.1-26.5]) (P < 0.001). The patients with uncomplicated malaria who were both IgG and IgM positive at admission had significantly shorter fever clearance times and lower admission parasitemia levels compared with those who were negative (P = 0.01 and P = 0.02, respectively). The median (range) in vitro parasite multiplication rate was significantly lower in cultures containing positive anti-RESA antibody plasma compared with those containing normal plasma (0.7 [0.1-3.5] versus 2.6 [0.1-12.1]; P < 0.001). These results suggest that antimalarial antibodies may play an important supportive role in the therapeutic response to antimalarial drugs during acute falciparum malaria.
spellingShingle Mayxay, M
Chotivanich, K
Pukrittayakamee, S
Newton, P
Looareesuwan, S
White, N
Contribution of humoral immunity to the therapeutic response in falciparum malaria.
title Contribution of humoral immunity to the therapeutic response in falciparum malaria.
title_full Contribution of humoral immunity to the therapeutic response in falciparum malaria.
title_fullStr Contribution of humoral immunity to the therapeutic response in falciparum malaria.
title_full_unstemmed Contribution of humoral immunity to the therapeutic response in falciparum malaria.
title_short Contribution of humoral immunity to the therapeutic response in falciparum malaria.
title_sort contribution of humoral immunity to the therapeutic response in falciparum malaria
work_keys_str_mv AT mayxaym contributionofhumoralimmunitytothetherapeuticresponseinfalciparummalaria
AT chotivanichk contributionofhumoralimmunitytothetherapeuticresponseinfalciparummalaria
AT pukrittayakamees contributionofhumoralimmunitytothetherapeuticresponseinfalciparummalaria
AT newtonp contributionofhumoralimmunitytothetherapeuticresponseinfalciparummalaria
AT looareesuwans contributionofhumoralimmunitytothetherapeuticresponseinfalciparummalaria
AT whiten contributionofhumoralimmunitytothetherapeuticresponseinfalciparummalaria